By Gordon Brown On Thursday, February 15th, 2018
0 Comments

Warren Buffett Boosts Teva With $358 Million Investment for 1.8%

Facebook0 Twitter Google Plus0 Pinterest0 Email   Teva shares rose 6% at the end of trading in New York after Berkshire Hathaway, the investment company controlled by Warren Buffett, revealed that it holds More...

By Shai Genish On Monday, January 15th, 2018
0 Comments

Israeli Authorities Fines Teva $22 Million for Corruption

Facebook0 Twitter Google Plus0 Pinterest0 Email After a $500 million penalty in the US, Teva Pharmaceutical will be fined NIS75 million in Israel for involvement in a corruption scandal in Eastern Europe, and More...

Meretzki, bio
By Shlomi Ella On Wednesday, December 20th, 2017
0 Comments

Israeli Breakthrough: Bone Graft Developed From Fat Tissue Implanted in a Patient’s Leg

Facebook0 Twitter Google Plus0 Pinterest0 Email The Israeli Biomed company Bonus Biogroup, announced Wednesday that it had implanted a bone graft in a leg of a patient suffering from a critical bone deficiency. The More...

By Shai Genish On Thursday, December 14th, 2017
0 Comments

Koch Brothers Are Leading $75-$150 Million Investment in InSightec Israel

Facebook3 Twitter Google Plus0 Pinterest0 Email   American conservative billionaires Charles and David Koch (Koch Brothers) are making their first investment in Israel. The brothers are leading between More...

By Jewish Business News On Thursday, December 14th, 2017
0 Comments

Crisis at Teva: Israel’s Greatest Battle of Layoffs

Facebook0 Twitter Google Plus0 Pinterest0 Email   The huge layoffs that Teva Pharmaceutical Industries is supposed to announce tomorrow will mark the beginning of a big battle with the company’s employees, More...

By Jewish Business News On Monday, December 4th, 2017
0 Comments

Israeli Clinical Stage Atox Bio Closes $30 Million Investment

Facebook0 Twitter Google Plus0 Pinterest0 Email Atox Bio, a clinical stage biotechnology company developing novel immunomodulators for critically ill patients, has raised $30 million. The round was led by Arix More...

By Jewish Business News On Tuesday, November 28th, 2017
0 Comments

New Israeli Cancer Therapy Demonstrates Promising Results

Facebook0 Twitter Google Plus0 Pinterest0 Email   The molecular biology lab of the Integrated Cancer Prevention Center (ICPC) at the Tel Aviv Sourasky Medical Center (TASMC), under the leadership of Prof. More...

By Jewish Business News On Monday, November 13th, 2017
0 Comments

JPMorgan, in a Rare Step, Recommends Selling Teva Shares

Facebook0 Twitter Google Plus0 Pinterest0 Email JPMorgan Bank today lowered Teva‘s rating (4,175.00.94% to the personal portfolio) and recommends selling Teva shares. This is due to concerns over the performance More...

By Jewish Business News On Monday, November 6th, 2017
0 Comments

Len Blavatnik Examines $3 Billion Investment in Teva

Facebook2 Twitter Google Plus0 Pinterest0 Email     Billionaire Len Blavatnik is considering investing $ 3 billion in Teva Pharmaceutical Industries, The Marker has learned. Blavatnik may acquire a More...

By Niva Goldberg On Thursday, October 19th, 2017
0 Comments

FDA Approves: Breakthrough in the Anti-Cancer Drug Developed by Israeli Company Kate Pharma

Facebook0 Twitter Google Plus0 Pinterest0 Email Less than two months after agreeing to buy Israeli company, Kate Pharma for $11.9 billion in cash, Pharma giant Gilead is making a breakthrough in the anti-cancer More...

Email:

Delivered by FeedBurner